C

CRSP

CRSP

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio64% buys
BearishBullish
CRSP Live QuoteReal-time
$38.93
$11.57(-22.91%)1M
Day Range$38.37 – $41.70
Open$40.49
Previous Close$40.19
Volume4.10M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.93B
P/E Ratio (TTM)24.5
Forward P/E23.4
EPS (TTM)$-4.73
Price to Book2.4
Dividend Yield0.65%
Beta (Volatility)1.90
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $38.93 (2%)
Low: $38.37High: $63.45
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$85.42-43.1% upside

Insider Buys

4

$53.00M

Insider Sales

42

$29.51M

Total Volume

$82.51M

73 transactions

Net Activity

+$23.49M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
73CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Moderate accumulation: purchases represent 64% of total transaction value.
  • •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys27 sells

$2018.48B total

G
2

George Simeon

Dir

1 buys1 sells

$52.22M total

K
3

Kulkarni Samarth

CEO

0 buys16 sells

$19.65M total

P
4

Prasad Raju

CFO

0 buys7 sells

$5.35M total

K
5

Kasinger James R.

GC, Secretary

0 buys11 sells

$2.36M total

Trading History
CRSP insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 19, 2026

1 months ago

Kulkarni Samarth

CEO

CEO
Sell47.8K$49.78$2.38M

Oct 14, 2026

1 months ago

George Simeon

Dir

Director
Sell14.5K$49.63$720K

Oct 14, 2026

1 months ago

Kulkarni Samarth

CEO

CEO
Sell4.1K$49.26$202K

Oct 14, 2026

1 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell1.0K$49.26$51K

Oct 6, 2026

1 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell2.0K$60.04$119K

Sep 22, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell94.8K$-10400.00$0

Sep 22, 2026

1 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell10.4K$60.24$626K

Sep 17, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.7K$-13679.00$0

Sep 17, 2026

2 months ago

Behbahani Ali

Dir

Director
Sell13.7K$57.09$781K

May 29, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell19.4K$-3786.00$0

May 29, 2026

5 months ago

Patel Naimish

Chief Medical Officer

C-Level
Sell3.8K$55.62$211K

Mar 23, 2026

8 months ago

Kulkarni Samarth

CEO

CEO
Sell10.0K$46.78$469K

Mar 23, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell94.3K$-3182.00$0

Mar 23, 2026

8 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell3.2K$46.78$149K

Mar 23, 2026

8 months ago

Prasad Raju

CFO

CFO
Sell3.7K$46.78$173K

Mar 16, 2026

8 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell3.5K$48.26$166K

Mar 16, 2026

8 months ago

Kulkarni Samarth

CEO

CEO
Sell10.3K$48.26$499K

Mar 16, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell13.1K$-3150.00$0

Mar 16, 2026

8 months ago

Prasad Raju

CFO

CFO
Sell9.9K$48.26$476K

Mar 16, 2026

8 months ago

Patel Naimish

Chief Medical Officer

C-Level
Sell3.1K$48.26$152K

Mar 11, 2026

8 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell2.8K$52.80$148K

Mar 11, 2026

8 months ago

Kulkarni Samarth

CEO

CEO
Sell9.8K$52.80$517K

Mar 11, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell87.8K$-2800.00$0

Feb 19, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell226.1K$-6967.00$0

Feb 19, 2026

9 months ago

Kulkarni Samarth

CEO

CEO
Sell7.0K$52.58$366K

Feb 19, 2026

9 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell2.1K$52.58$111K

Apr 3, 2025

19 months ago

Patel Naimish

Chief Medical Officer

C-Level
Buy1.5K$32.96$50K

Apr 3, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.5K$1508.00$2.27M

Jan 22, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.8K$-34972.00$0

Jan 22, 2026

10 months ago

Prasad Raju

CFO

CFO
Sell35.0K$60.19$2.10M

Jan 20, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell219.8K$-90000.00$0

Jan 20, 2026

10 months ago

Kulkarni Samarth

CEO

CEO
Sell90.0K$57.40$5.17M

Jan 6, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.8K$-29700.00$0

Jan 6, 2026

10 months ago

Prasad Raju

CFO

CFO
Sell29.7K$60.16$1.79M

Dec 22, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell6.8K$-10000.00$0

Dec 22, 2025

11 months ago

Prasad Raju

CFO

CFO
Sell10.0K$55.95$560K

Oct 17, 2025

13 months ago

Kulkarni Samarth

CEO

CEO
Sell50.9K$67.91$3.46M

Oct 17, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell339.9K$-50895.00$0

Oct 14, 2025

13 months ago

Kulkarni Samarth

CEO

CEO
Sell4.2K$66.60$283K

Oct 14, 2025

13 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell1.1K$66.60$72K

Oct 14, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell290.8K$-4242.00$0

Aug 18, 2025

15 months ago

Kulkarni Samarth

CEO

CEO
Sell13.1K$58.15$761K

Aug 18, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell292.6K$-13081.00$0

Aug 6, 2025

15 months ago

Treco Douglas A

Dir

Director
Buy20.0K$57.03$1.14M

Aug 6, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell22.0K$20000.00$440.00M

Jul 16, 2025

16 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.04M$989812.00$2017.99B

Jul 16, 2025

16 months ago

George Simeon

Dir

Director
Buy989.8K$52.03$51.50M

May 29, 2025

18 months ago

Patel Naimish

Chief Medical Officer

C-Level
Sell3.9K$35.94$141K

May 29, 2025

18 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.1K$-3932.00$0

Mar 21, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell280.7K$-10031.00$0

Mar 21, 2025

20 months ago

Prasad Raju

CFO

CFO
Sell2.2K$41.23$91K

Mar 21, 2025

20 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell3.2K$41.23$131K

Mar 21, 2025

20 months ago

Bruno Julianne

COO

COO
Sell1.7K$41.23$71K

Mar 21, 2025

20 months ago

Kulkarni Samarth

CEO

CEO
Sell10.0K$41.23$414K

Mar 17, 2025

20 months ago

Prasad Raju

CFO

CFO
Sell3.8K$41.80$157K

Mar 17, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell12.7K$-3762.00$0

Mar 11, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell271.1K$-14435.00$0

Mar 11, 2025

20 months ago

Kulkarni Samarth

CEO

CEO
Sell14.4K$42.70$616K

Mar 11, 2025

20 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell4.0K$42.67$169K

Mar 11, 2025

20 months ago

Bruno Julianne

COO

COO
Sell1.4K$42.54$59K

Feb 26, 2025

21 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell7.0K$7000.00$49.00M

Feb 26, 2025

21 months ago

Greene John

Dir

Director
Buy7.0K$44.85$314K

Feb 19, 2025

21 months ago

Kulkarni Samarth

CEO

CEO
Sell18.4K$55.21$1.01M

Feb 19, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell257.2K$-18360.00$0

Feb 18, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell275.6K$-18568.00$0

Feb 18, 2025

21 months ago

Kasinger James R.

GC, Secretary

General Counsel
Sell11.5K$53.67$619K

Feb 18, 2025

21 months ago

Kulkarni Samarth

CEO

CEO
Sell18.6K$54.21$1.01M

Feb 19, 2025

21 months ago

Bruno Julianne

COO

COO
Sell333$52.80$18K

Dec 2, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell267.2K$-15000.00$0

Dec 2, 2024

23 months ago

Kulkarni Samarth

CEO

CEO
Sell15.0K$55.10$827K

Nov 11, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell282.2K$-30000.00$0

Nov 11, 2024

24 months ago

Kulkarni Samarth

CEO

CEO
Sell30.0K$55.62$1.67M

Oct 14, 2024

25 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell62.6K$-1089.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CRSP Buy Conviction64%
Industry Rank#0 of 569
Volume Contribution0.5%
Total Industry Activity$16.52B

CRSP has an insider buy conviction of 64%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CRSP

Over the last 90 days, corporate insiders at CRSP (CRSP) engaged in a total of 73 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 42 were sales. The total volume of insider trading reached $82.51M.

The net insider activity for CRSP shows a net buying bias of $23.49M. This activity represents a 64% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.04M shares valued at $2017.99B on Jul 16, 2025.

Live Market News & Developments
Aggregated real-time headlines for CRSP (CRSP)
6 updates

CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History

Yahoo! Finance Canada2d ago

Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors.

Barchart.com51d ago

CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As It Names A New CTO

Yahoo Finance17d ago

CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base

Webull50d ago

After gifting stock, the CEO of CRISPR Therapeutics (CRSP) reported holding 211,899 shares directly.

Stock Titan18h ago

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Tops Revenue Estimates

Yahoo Finance18d ago

FAQs About CRSP Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CRSP.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CRSP is currently 73/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 4 purchases and 42 sales by company executives over the last 90 days.

The CEO Conviction Index for CRSP is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.